原发性肝癌的肝段动脉栓塞治疗  

Segmental transcatheter arterial embolization for primary hepatocellular carcinoma

作　　者：李立[1] 林浩皋[1] 张伟章[1] 李锦清[1] 张亚奇[1] 伍尧泮[1] 

机构地区：[1]中山医科大学肿瘤医院放诊科,广州510060

出　　处：《肿瘤防治研究》1998年第1期49-51,共3页Cancer Research on Prevention and Treatment

基　　金：95'国家科委科技人员攻关课题资助

摘　　要：本文报道50例肝癌肝段动脉栓塞治疗的1年、2年、3年、4年累积生存率分别83．8％，65．4％，42．9％，24．5％，总结分析了瘤周门脉碘油逆流的表现ê脉逆流出现率为64％，作者认为肿瘤周围出现门脉碘油逆流是肿瘤碘油栓塞完全的标志之一，可对肿瘤门脉供血起部分栓塞作用。The 1 -,2 -, 3 -, 4 - year cumulative survival rates of 50 cases of segmentaltranscatheter arterial embolization for primary hepatocellular carcinoma were 83. 8%,65. 4 %, 42. 9 %, 24. 5 %. The manifestation and clinical value of lipiodol overflow intoportal veins surrounding the tumor were discussed in our study. The occurrence rate ofthe lipiodol over - flow into portal veins in segmental TAE was 64%, We suggestedthat the lipiodol overflow into portal veins was one of marks of complete embolizationfor tumors, and may played a part role in embolizating the portal venous supply of thehepatocellular carcinoma.

关 键 词：肝肿瘤 肝动脉栓塞 栓塞疗法 

分 类 号：R735.705[医药卫生—肿瘤]